[Form 4] Peapack-Gladstone Financial Corp Insider Trading Activity

Rhea-AI Filing Summary

AMERISAFE, Inc. (AMSF) filed an 8-K on 24-Jul-2025 to disclose that its Board has reauthorized a share-repurchase program of up to $25.0 million. The new authorization replaces the prior program and carries no expiration date. Repurchases may be executed in the open market or through Rule 10b5-1 trading plans and will be funded with available capital. The Board retains full discretion to modify, suspend, increase or terminate the program at any time, based on market conditions and regulatory factors. The filing contains no earnings data and does not obligate the company to repurchase any specific amount of shares.

Positive

• $25 million share-repurchase authorization renews and potentially expands capital-return capacity, demonstrating Board confidence and offering share-price support.

Negative

• No commitment or timeline—the Board may alter or suspend the program at will, so actual repurchase volume and timing remain uncertain.

Insights

Equity Research Analyst

TL;DR: $25M buyback adds capital-return flexibility and could support EPS, but scale is modest.

The reauthorization signals management’s confidence in cash generation and seeks to offset share dilution or enhance shareholder returns. With no expiry, the Board can time purchases opportunistically, a prudent approach in insurance markets that can be volatile. That said, the filing gives no guidance on execution pace, leaving the actual impact dependent on utilization. Still, at up to $25 million, the program could retire roughly 3-4% of shares outstanding (based on a sub-$700M market cap in recent quarters), providing a mild EPS tailwind if fully deployed.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

KENNEDY DOUGLAS L

(Last) (First) (Middle)

500 HILLS DRIVE, SUITE 300

PO BOX 700

(Street)

BEDMINSTER NJ 07921

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PEAPACK GLADSTONE FINANCIAL CORP [ PGC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
07/23/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/23/2025		P		3,720	A	$26.244	39,128.749	D
Common Stock								207,136	I	Rabbi Trust(1)
Common Stock								18,493	I	401(k)(2)
Common Stock								10,893.341	I	Employee Stock Purchase Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restrictued Stock Units	(3)							(4)	(4)	Common Stock	11,689		11,689	D
Restricted Stock Units	(3)							(5)	(5)	Common Stock	17,836		17,836	D
Restricted Stock Units	(6)							(7)	(7)	Common Stock	43,742		43,742	D
Phantom Stock	(8)							(9)	(9)	Common Stock	6,881		6,881	D
Phantom Stock	(8)							(10)	(10)	Common Stock	2,828		2,828	D
Phantom Stock	(11)							(12)	(12)	Common Stock	15,482		15,482	D

Explanation of Responses:

1. Held indirectly through a rabbi trust pursuant to a non-qualified deferred compensation plan.

2. Includes 401(k) contributions used to purchase PGC stock.

3. Each restricted stock unit represents a contingent right to receive one share of common stock of Peapack-Gladstone Financial Corporation.

4. The restricted stock units vest and settle in stock in three approximately equal installments on each of the first three anniversaries of the grant date.

5. The restricted stock units vest and settle in stock in five approximately equal installments on each of the first five anniversaries of the grant date.

6. Each restricted stock unit represents the right to receive one share of common stock of Peapack-Gladstone Financial Corporation subject to certain performance conditions. The units will cliff vest, after three years, if the conditions are met.

7. The restricted stock units will cliff vest on the third anniversary of the grant date subject to certain performance conditions being satisfied.

8. Each share of phantom stock is the economic equivalent of one share of common stock.

9. The phantom stock is scheduled to vest in three approximately equal installments on each of the first three anniversaries of the grant date.

10. The phantom stock is scheduled to vest in five approximately equal installments on each of the first five anniversaries of the grant date.

11. Each share of phantom stock represents the right to receive the economic equivalent of one share of common stock subject to certain perfomance conditions. The phantom stock will cliff vest , after three years, if the conditions are met.

12. The phantom stock will cliff vest on the third annivesary of the grant date subject to certain performance conditions being satisfied.

	Douglas L. Kennedy	07/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did AMERISAFE (AMSF) announce on July 24, 2025?

The Board reauthorized a $25 million share-repurchase program with no expiration date.

Does the new buyback replace a prior program?

Yes. The $25 million authorization replaces the company’s previous repurchase program.

How will AMERISAFE fund the repurchases?

Future share purchases are expected to be funded from available capital.

Is AMERISAFE obligated to repurchase the full $25 million?

No. The program is discretionary; the Board may modify, suspend, or terminate it at any time.

Can AMERISAFE use Rule 10b5-1 trading plans?

Yes. Repurchases may occur under Rule 10b5-1 compliant trading plans.